Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population

• Main Authors: Amir TAJBAKHSH (Author), Zahra FARJAMI (Author), Abolfazl NESAEI-BAJESTANI (Author), Fahimeh AFZALJAVAN (Author), Mahdi RIVANDI (Author), Atefeh MOEZZI (Author), Soheila ABEDINI (Author), Mahla ASGHARI (Author), Mohammad Mahdi KOOSHYAR (Author), Fatemeh HOMAEI SHANDIZ (Author), Alireza PASDAR (Author)
• Format: Book
• Published: Tehran University of Medical Sciences, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: CC chemokine receptor 5 (CCR5) is introduced as an immune response modulator. The activity of CCR5 influences breast tumour development in a p53-dependent manner. This study aimed to investigate the frequency of CCR5delta32 and its association with the risk of breast cancer in 1038 blood...